Ranbaxy Laboratories shares fell on Friday after the leading financial daily reported the company may have to pay fine of Rs 2.4 billion imposed by the State of Texas related to slippages from the US-prescribed manufacturing practice on drugs.

Shares of the company are trading at Rs 631.90, down Rs 9.2, or 1.44% at the Bombay Stock Exchange (BSE) on Friday at 10:56 a.m.

The scrip has touched an intra-day high of Rs 635.90 and low of Rs 626.60. The total volume of shares traded at the BSE is 89,090.

In the earlier session, the shares gained 1.83%, or Rs 11.55, at Rs 641.10.